JP7053966B2 - 樹脂製容器に充填された銀塩含有眼科用水性組成物 - Google Patents

樹脂製容器に充填された銀塩含有眼科用水性組成物 Download PDF

Info

Publication number
JP7053966B2
JP7053966B2 JP2021552932A JP2021552932A JP7053966B2 JP 7053966 B2 JP7053966 B2 JP 7053966B2 JP 2021552932 A JP2021552932 A JP 2021552932A JP 2021552932 A JP2021552932 A JP 2021552932A JP 7053966 B2 JP7053966 B2 JP 7053966B2
Authority
JP
Japan
Prior art keywords
aqueous
ophthalmic composition
ophthalmology
aqueous ophthalmic
silver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021552932A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021199814A1 (enExample
Inventor
雄介 桃川
真希 飯田
博之 浅田
豊実 藤澤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of JPWO2021199814A1 publication Critical patent/JPWO2021199814A1/ja
Priority to JP2022058115A priority Critical patent/JP7169477B2/ja
Application granted granted Critical
Publication of JP7053966B2 publication Critical patent/JP7053966B2/ja
Priority to JP2022171413A priority patent/JP7721498B2/ja
Priority to JP2025126160A priority patent/JP2025146955A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Bridges Or Land Bridges (AREA)
JP2021552932A 2020-03-31 2021-02-26 樹脂製容器に充填された銀塩含有眼科用水性組成物 Active JP7053966B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2022058115A JP7169477B2 (ja) 2020-03-31 2022-03-31 樹脂製容器に充填された銀塩含有眼科用水性組成物
JP2022171413A JP7721498B2 (ja) 2020-03-31 2022-10-26 樹脂製容器に充填された銀塩含有眼科用水性組成物
JP2025126160A JP2025146955A (ja) 2020-03-31 2025-07-29 樹脂製容器に充填された銀塩含有眼科用水性組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020062252 2020-03-31
JP2020062252 2020-03-31
PCT/JP2021/007366 WO2021199814A1 (ja) 2020-03-31 2021-02-26 樹脂製容器に充填された銀塩含有眼科用水性組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022058115A Division JP7169477B2 (ja) 2020-03-31 2022-03-31 樹脂製容器に充填された銀塩含有眼科用水性組成物

Publications (2)

Publication Number Publication Date
JPWO2021199814A1 JPWO2021199814A1 (enExample) 2021-10-07
JP7053966B2 true JP7053966B2 (ja) 2022-04-12

Family

ID=77930318

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2021552932A Active JP7053966B2 (ja) 2020-03-31 2021-02-26 樹脂製容器に充填された銀塩含有眼科用水性組成物
JP2022058115A Active JP7169477B2 (ja) 2020-03-31 2022-03-31 樹脂製容器に充填された銀塩含有眼科用水性組成物
JP2022171413A Active JP7721498B2 (ja) 2020-03-31 2022-10-26 樹脂製容器に充填された銀塩含有眼科用水性組成物
JP2025126160A Pending JP2025146955A (ja) 2020-03-31 2025-07-29 樹脂製容器に充填された銀塩含有眼科用水性組成物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2022058115A Active JP7169477B2 (ja) 2020-03-31 2022-03-31 樹脂製容器に充填された銀塩含有眼科用水性組成物
JP2022171413A Active JP7721498B2 (ja) 2020-03-31 2022-10-26 樹脂製容器に充填された銀塩含有眼科用水性組成物
JP2025126160A Pending JP2025146955A (ja) 2020-03-31 2025-07-29 樹脂製容器に充填された銀塩含有眼科用水性組成物

Country Status (8)

Country Link
US (1) US20230145529A1 (enExample)
EP (1) EP4129341A4 (enExample)
JP (4) JP7053966B2 (enExample)
KR (2) KR102705675B1 (enExample)
CN (1) CN115348871B (enExample)
CA (1) CA3176584A1 (enExample)
TW (1) TWI896607B (enExample)
WO (1) WO2021199814A1 (enExample)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005330276A (ja) 2004-04-23 2005-12-02 Rohto Pharmaceut Co Ltd 防腐剤及びこれを含有する水性組成物
JP2006162648A (ja) 2004-12-02 2006-06-22 Konica Minolta Business Technologies Inc 現像装置及び画像形成装置
JP2016179960A (ja) 2015-03-24 2016-10-13 ロート製薬株式会社 眼科用組成物
WO2020059474A1 (ja) 2018-09-21 2020-03-26 小林製薬株式会社 医薬組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
JP4683835B2 (ja) * 2003-12-01 2011-05-18 ロート製薬株式会社 防腐剤及びこれを含有する水性組成物
KR100557679B1 (ko) * 2004-01-07 2006-03-07 뉴바이오 (주) 4차암모늄의 공중합에 의한 콘택트렌즈제조방법
BRPI0818459A2 (pt) * 2007-10-16 2015-04-14 Sun Pharma Advanced Res Co Ltd Composição farmacêutica adequada para uso oftálmico.
IN2014MN01555A (enExample) * 2012-02-27 2015-07-03 Rohto Pharma
KR20150119303A (ko) * 2013-02-15 2015-10-23 센주 세이야꾸 가부시키가이샤 항균성 금속을 함유하는 디플루프레드네이트 유액 조성물
US20160022648A1 (en) * 2013-03-13 2016-01-28 Santen Pharmaceutical Co., Ltd. Therapeutic agent for meibomian gland dysfunction
SG11201705138QA (en) * 2014-12-25 2017-07-28 Santen Pharmaceutical Co Ltd Aqueous ophthalmic solution
TWI711453B (zh) 2015-06-05 2020-12-01 日商參天製藥股份有限公司 抑制水性點眼液中之洛赫西定類的殘存率降低之方法
JP6615548B2 (ja) * 2015-08-06 2019-12-04 ロート製薬株式会社 眼科組成物
JP7317714B2 (ja) * 2017-12-01 2023-07-31 参天製薬株式会社 眼科用製品
US11602561B2 (en) * 2018-06-28 2023-03-14 Csp Advanced Solutions Inc. Treatment method and system for epidemic keratoconjunctivitis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005330276A (ja) 2004-04-23 2005-12-02 Rohto Pharmaceut Co Ltd 防腐剤及びこれを含有する水性組成物
JP2006162648A (ja) 2004-12-02 2006-06-22 Konica Minolta Business Technologies Inc 現像装置及び画像形成装置
JP2016179960A (ja) 2015-03-24 2016-10-13 ロート製薬株式会社 眼科用組成物
WO2020059474A1 (ja) 2018-09-21 2020-03-26 小林製薬株式会社 医薬組成物

Also Published As

Publication number Publication date
CN115348871A (zh) 2022-11-15
CA3176584A1 (en) 2021-10-07
JP2025146955A (ja) 2025-10-03
US20230145529A1 (en) 2023-05-11
KR20220161379A (ko) 2022-12-06
WO2021199814A1 (ja) 2021-10-07
JP7169477B2 (ja) 2022-11-10
JP2023001184A (ja) 2023-01-04
JPWO2021199814A1 (enExample) 2021-10-07
JP2022087168A (ja) 2022-06-09
EP4129341A4 (en) 2024-04-24
JP7721498B2 (ja) 2025-08-12
KR102705675B1 (ko) 2024-09-11
EP4129341A1 (en) 2023-02-08
CN115348871B (zh) 2025-08-08
KR20240135080A (ko) 2024-09-10
TW202203920A (zh) 2022-02-01
TWI896607B (zh) 2025-09-11

Similar Documents

Publication Publication Date Title
CN112969465B (zh) 抑制软性隐形眼镜变质的眼科用组合物
US9694003B2 (en) Formulations and methods for treating high intraocular pressure
JP6903448B2 (ja) ドルゾラミドとブリモニジンを含む医薬組成物
KR102766744B1 (ko) 점안제
JP2025505557A (ja) 多回投与眼科用組成物
JP7053966B2 (ja) 樹脂製容器に充填された銀塩含有眼科用水性組成物
GR1009419B (el) Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου
JP6702754B2 (ja) ドルゾラミドを含有する防腐剤
JP7144630B2 (ja) レバミピドまたはその塩および高分子を含有する水性懸濁液
TW202404569A (zh) 含有賽佩普斯特(Sepetaprost)之眼科用組合物
JP6877613B2 (ja) 防腐効果のある医薬の組合せ
HK40071193B (zh) 软性隐形眼镜用药物组合物
TW202517277A (zh) 含有賽佩普斯特(Sepetaprost)之點眼液

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210906

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210906

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20210906

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20210907

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211214

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220128

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220329

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220331

R150 Certificate of patent or registration of utility model

Ref document number: 7053966

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R153 Grant of patent term extension

Free format text: JAPANESE INTERMEDIATE CODE: R153

R153 Grant of patent term extension

Free format text: JAPANESE INTERMEDIATE CODE: R153

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250